Dr Claire Shepherd
Tabs
Publications related to this Person
Book Chapters
Jezewski RC; Halliday GM; Shepherd CE, 2021, 'The aging brain and brain banking', in Assessments, Treatments and Modeling in Aging and Neurological Disease: The Neuroscience of Aging, Elsevier, pp. 103 - 112, http://dx.doi.org/10.1016/B978-0-12-818000-6.00010-X
Gregory GC; Shepherd CE; Halliday GM, 2007, 'Physiologic and neurotoxic properties of Abeta peptides', in Barrow CJ; Small DH (ed.), Abeta Peptide and Alzheimer`s Disease, Springer Verlag, London, pp. 179 - 197, http://dx.doi.org/10.1007/978-1-84628-440-3_11
Journal articles
Mazumder S; Bahar AY; Shepherd CE; Prasad AA, 2022, 'Post-mortem brain histological examination in the substantia nigra and subthalamic nucleus in Parkinson’s disease following deep brain stimulation', Frontiers in Neuroscience, vol. 16, pp. 948523, http://dx.doi.org/10.3389/fnins.2022.948523
Mccann H; Bahar AY; Burkhardt K; Gardner AJ; Halliday GM; Iverson GL; Shepherd CE, 2022, 'Prevalence of chronic traumatic encephalopathy in the Sydney Brain Bank', Brain Communications, vol. 4, http://dx.doi.org/10.1093/braincomms/fcac189
Forrest SL; Kim JH; De Sousa C; Cheong R; Crockford DR; Sheedy D; Stevens J; McCrossin T; Tan RH; McCann H; Shepherd CE; Rowe DB; Kiernan MC; Halliday GM; Kril JJ, 2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, vol. 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849
McCann H; Durand B; Shepherd CE, 2021, 'Aging-related tau astrogliopathy in aging and neurodegeneration', Brain Sciences, vol. 11, pp. 927 - 927, http://dx.doi.org/10.3390/brainsci11070927
Forrest SL; Shepherd CE; McCann H; Kwok JB; Halliday GM; Kril JJ, 2021, 'Globular glial tauopathy with a mutation in MAPT and unusual TDP-43 proteinopathy in a patient with behavioural-variant frontotemporal dementia', Acta Neuropathologica, vol. 141, pp. 791 - 794, http://dx.doi.org/10.1007/s00401-021-02297-0
Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Gregory G; Small DH; Halliday GM, 2020, 'Alzheimer's amyloid-β and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue', Brain and Behavior, vol. 10, pp. e01672 - e01672, http://dx.doi.org/10.1002/brb3.1672
Forrest SL; Halliday GM; Shepherd CE; Kwok JB; Hallupp M; Kril JJ, 2020, 'Are mutations in MAPT associated with GGT type III?', Neuropathology and Applied Neurobiology, vol. 46, pp. 406 - 409, http://dx.doi.org/10.1111/nan.12583
Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Halliday GM, 2020, 'Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology', Neurobiology of Aging, vol. 89, pp. 129 - 131, http://dx.doi.org/10.1016/j.neurobiolaging.2019.10.025
Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC, 2020, 'Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease', Alzheimer's Research and Therapy, vol. 12, pp. 22, http://dx.doi.org/10.1186/s13195-020-00587-5
Symons GF; Clough M; Fielding J; O'Brien WT; Shepherd CE; Wright DK; Shultz SR, 2020, 'The Neurological Consequences of Engaging in Australian Collision Sports', Journal of Neurotrauma, vol. 37, pp. 792 - 809, http://dx.doi.org/10.1089/neu.2019.6884
Dobson-Stone C; Hallupp M; Shahheydari H; Ragagnin AMG; Chatterton Z; Carew-Jones F; Shepherd CE; Stefen H; Paric E; Fath T; Thompson EM; Blumbergs P; Short CL; Field CD; Panegyres PK; Hecker J; Nicholson G; Shaw AD; Fullerton JM; Luty AA; Schofield PR; Brooks WS; Rajan N; Bennett MF; Bahlo M; Shankaracharya ; Landers JE; Piguet O; Hodges JR; Halliday GM; Topp SD; Smith BN; Shaw CE; McCann E; Fifita JA; Williams KL; Atkin JD; Blair IP; Kwok JB, 2020, 'CYLD is a causative gene for frontotemporal dementia - Amyotrophic lateral sclerosis', Brain, vol. 143, pp. 783 - 799, http://dx.doi.org/10.1093/brain/awaa039
Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC, 2020, 'Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s Disease', , http://dx.doi.org/10.21203/rs.2.17082/v2
Orme T; Hernandez D; Ross OA; Kun-Rodrigues C; Darwent L; Shepherd CE; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday G; Stone DJ; Dickson DW; Hardy J; Singleton A; Guerreiro R; Bras J, 2020, 'Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies', Acta Neuropathologica Communications, vol. 8, http://dx.doi.org/10.1186/s40478-020-0879-z
Forrest SL; Halliday GM; Sizemova A; van Roijen M; McGinley CV; Bright F; Kapur M; McGeachie AB; McCann H; Shepherd CE; Tan RH; Affleck AJ; Huang Y; Kril JJ, 2020, 'A practical approach to differentiate the frontotemporal tauopathy subtypes', Journal of Neuropathology and Experimental Neurology, vol. 79, pp. 1122 - 1126, http://dx.doi.org/10.1093/jnen/nlaa100
Jeżewski RC; Poljak A; Mather KA; Sachdev PS; Shepherd CE, 2020, 'The prevalence of limbic‐predominant age‐related TDP‐43 encephalopathy in the Sydney brain bank', Alzheimer's & Dementia, vol. 16, http://dx.doi.org/10.1002/alz.037885
Shepherd CE; McGeachie AB; Affleck AJ; Halliday GM, 2019, 'Letter to the editor', Journal of Neuropathology and Experimental Neurology, vol. 78, pp. 975, http://dx.doi.org/10.1093/jnen/nlz069
Guerreiro R; Escott-Price V; Hernandez DG; Kun-Rodrigues C; Ross OA; Orme T; Neto JL; Carmona S; Dehghani N; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J, 2019, 'Heritability and genetic variance of dementia with Lewy bodies', Neurobiology of Disease, vol. 127, pp. 492 - 501, http://dx.doi.org/10.1016/j.nbd.2019.04.004
Forrest SL; Crockford DR; Sizemova A; Mccann H; Shepherd CE; Mcgeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; Mcginley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM, 2019, 'Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration', Neurology, vol. 92, pp. e2472 - e2482, http://dx.doi.org/10.1212/WNL.0000000000007530
Shepherd CE; Alvendia H; Halliday GM, 2019, 'Brain Banking for Research into Neurodegenerative Disorders and Ageing', Neuroscience Bulletin, vol. 35, pp. 283 - 288, http://dx.doi.org/10.1007/s12264-018-0326-3
Kun-Rodrigues C; Orme T; Carmona S; Hernandez DG; Ross OA; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Guerreiro R; Bras J, 2019, 'A comprehensive screening of copy number variability in dementia with Lewy bodies', Neurobiology of Aging, vol. 75, pp. 223.e1 - 223.e10, http://dx.doi.org/10.1016/j.neurobiolaging.2018.10.019
Bhatia S; Kim WS; Shepherd CE; Halliday GM, 2019, 'Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia', Journal of Molecular Neuroscience, vol. 67, pp. 125 - 132, http://dx.doi.org/10.1007/s12031-018-1217-9
Tan RH; Yang Y; McCann H; Shepherd C; Halliday GM; Whitwell J, 2019, 'Von economo neurons in behavioral variant frontotemporal dementia with underlying Alzheimer's disease', Journal of Alzheimer's Disease, vol. 69, pp. 963 - 967, http://dx.doi.org/10.3233/JAD-180900
Guerreiro R; Orme T; Neto JL; Bras J; Hardy J; Kun-Rodrigues C; Darwent L; Neto J; Carmona S; Ansorge O; Parkkinen L; Morgan K; Brown K; Braae A; Barber I; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Revesz T; Lees A; Zetterberg H; Escott-Price V; Pickering-Brown S; Mann D; Singleton A; Hernandez D; Ross O; Dickson D; Graff-Radford N; Ferman T; Petersen R; Boeve B; Heckman M; Trojanowski JQ; Van Deerlin V; Cairns N; Morris J; Stone DA; Eicher J; Clark L; Honig L; Marder K; Serrano G; Beach T; Galasko D; Masliah E; Rogaeva E; St. George-Hyslop P; Clarimon J; Lleo A; Morenas-Rodriguez E; Pastor P; Diez-Fairen M; Aquilar M; Shepherd C; Halliday G; Tienari P; Myllykangas L; Oinas M; Santana I; Lesage S; Londos E; Lemstra A, 2018, 'LRP10 in α-synucleinopathies', The Lancet Neurology, vol. 17, pp. 1032 - 1033, http://dx.doi.org/10.1016/S1474-4422(18)30399-5
Paradise M; Shepherd CE; Wen W; Sachdev PS, 2018, 'Neuroimaging and neuropathology indices of cerebrovascular disease burden: A systematic review', Neurology, vol. 91, pp. 310 - 320, http://dx.doi.org/10.1212/wnl.0000000000005997
Morales-Briceño H; Cruse B; Fois AF; Lin MW; Jiang J; Banerjee D; Grunstein R; Varikatt W; Rodriguez M; Shepherd C; Fung VSC, 2018, 'IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease', Neurology, vol. 90, pp. 1106 - 1112, http://dx.doi.org/10.1212/WNL.0000000000005679
Shepherd CE; Yang Y; Halliday GM, 2018, 'Region- and Cell-specific Aneuploidy in Brain Aging and Neurodegeneration', Neuroscience, vol. 374, pp. 326 - 334, http://dx.doi.org/10.1016/j.neuroscience.2018.01.050
Guerreiro R; Ross OA; Kun-Rodrigues C; Hernandez DG; Orme T; Eicher JD; Shepherd CE; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J, 2018, 'Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study', The Lancet Neurology, vol. 17, pp. 64 - 74, http://dx.doi.org/10.1016/S1474-4422(17)30400-3
Guerreiro R; Escott-Price V; Hernandez D; Kun-Rodrigues C; Ross O; Orme T; Luis Neto J; Carmona S; Dehghani N; Eicher J; Shepherd C; Parkkinen L; Darwent L; Heckman M; Scholz S; Troncoso J; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig L; Marder K; Lemstra A; Rogaeva E; George-Hyslop PS; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano G; Beach T; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari P; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve B; Petersen R; Ferman T; Graff-Radford N; Cairns N; Morris J; Pickering-Brown S; Mann D; Halliday G; Hardy J; Trojanowski J; Dickson D; Singleton A; Stone D; Bras J; for the International Parkinson’s Disease Genomics Consortium , 2018, 'Heritability and genetic variance of dementia with Lewy bodies', , http://dx.doi.org/10.1101/454249
Dore V; Bourgeat P; Cummins TL; Raniga P; Williams S; Amadoru S; MacLean C; Hinton F; Shepherd C; Halliday GM; Leyton CE; Hodges JR; Ames D; Martins RN; Masters CL; Fripp J; Salvado O; Villemagne VL; Rowe C, 2018, 'IC‐P‐008: VISUAL ASSESSMENT OF β‐AMYLOID PET SCAN IS IMPROVED BY CAPAIBL', Alzheimer's & Dementia, vol. 14, pp. P18 - P19, http://dx.doi.org/10.1016/j.jalz.2018.06.2072
Dore V; Bourgeat P; Cummins TL; Raniga P; Williams S; Amadoru S; MacLean C; Hinton F; Shepherd C; Halliday GM; Leyton CE; Hodges JR; Ames D; Martins RN; Masters CL; Fripp J; Salvado O; Villemagne VL; Rowe C, 2018, 'P1‐405: VISUAL ASSESSMENT OF β‐AMYLOID PET SCAN IS IMPROVED BY CAPAIBL', Alzheimer's & Dementia, vol. 14, pp. P459 - P459, http://dx.doi.org/10.1016/j.jalz.2018.06.414
Yang Y; Shepherd CE; Halliday GM, 2017, 'Increased aneuploidy is not a universal feature across α-synucleinopathies', Movement Disorders, vol. 32, pp. 475 - 476, http://dx.doi.org/10.1002/mds.26869
Kun-Rodrigues C; Ross OA; Orme T; Shepherd C; Parkkinen L; Darwent L; Hernandez D; Ansorge O; Clark LN; Honig LS; Marder K; Lemstra A; Scheltens P; van der Flier W; Louwersheimer E; Holstege H; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Clarimon J; Lleó A; Morenas-Rodríguez E; Lesage S; Galasko D; Masliah E; Santana I; Diez M; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Stone DJ; Pickering-Brown S; Mann D; Dickson DW; Halliday GM; Singleton A; Guerreiro R; Bras J, 2017, 'Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies', Neurobiology of Aging, vol. 49, pp. 214.e13 - 214.e15, http://dx.doi.org/10.1016/j.neurobiolaging.2016.08.023
Leshchyns'Ka I; Liew HT; Shepherd C; Halliday GM; Stevens CH; Ke YD; Ittner LM; Sytnyk V, 2015, 'Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease', Nature Communications, vol. 6, http://dx.doi.org/10.1038/ncomms9836
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JBJ; Hodges JR; Kiernan MC; Halliday GM, 2015, 'TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes', Brain, vol. 138, pp. 3110 - 3122, http://dx.doi.org/10.1093/brain/awv220
Yang Y; Shepherd C; Halliday G, 2015, 'Aneuploidy in Lewy body diseases', Neurobiology of Aging, vol. 36, pp. 1253 - 1260, http://dx.doi.org/10.1016/j.neurobiolaging.2014.12.016
Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS, 2014, 'Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis', Acta Neuropathologica Communications, vol. 2, http://dx.doi.org/10.1186/2051-5960-2-9
Tan RH; Shepherd CE; Kril JJ; McCann H; McGeachie A; McGinley C; Affleck A; Halliday GM, 2014, 'Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43', Acta Neuropathologica Communications, vol. 2, pp. 33, http://dx.doi.org/10.1186/2051-5960-1-33
Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C, 2014, 'Cofilin rods and aggregates concur with tau pathology and the development of alzheimer's disease', Journal of Alzheimer's Disease, vol. 42, pp. 1443 - 1460, http://dx.doi.org/10.3233/JAD-140393
Bhatia S; Jenner AM; Li H; Ruberu K; Spiro AS; Shepherd CE; Kril JJ; Kain N; Don A; Garner B, 2013, 'Increased apolipoprotein D dimer formation in alzheimer's disease hippocampus is associated with lipid conjugated diene levels', Journal of Alzheimer's Disease, vol. 35, pp. 475 - 486, http://dx.doi.org/10.3233/JAD-122278
Lim YA; Giese M; Shepherd CE; Halliday GM; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Gotz J, 2012, 'Role of hippocalcin in mediating Abeta toxicity', Biochimica et Biophysica ACTA - Molecular Basis of Disease, vol. 1822, pp. 1247 - 1257, http://dx.doi.org/10.1016/j.bbadis.2012.04.007
Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok J, 2012, 'C9ORF72 repeat expansion in clinical and neuropathological frontotemporal dementia cohorts', Neurology, vol. 79, pp. 995 - 1001, http://dx.doi.org/10.1212/WNL.0b013e3182684634
Kerr ML; Gasperini R; Gibbs ME; Hou X; Shepherd CE; Strickland DK; Foa L; Lawen A; Small D, 2010, 'Inhibition of AB aggregation and neurotoxicity by the 39-kDa receptor-associated protein', Journal of Neurochemistry, vol. 112, pp. 1199 - 1209, http://dx.doi.org/10.1111/j.1471-4159.2009.06540.x
Mitew S; Kirkcaldie MTK; Halliday GM; Shepherd CE; Vickers JC; Dickson TC, 2010, 'Focal demyelination in Alzheimer's disease and transgenic', ACTA Neuropathologica, vol. 119, pp. 567 - 577, http://dx.doi.org/10.1007/s00401-010-0657-2
Shepherd CE; Mccann H; Halliday GM, 2009, 'Variations in the neuropathology of familial Alzheimer's disease', ACTA Neuropathologica, vol. 118, pp. 37 - 52, http://dx.doi.org/10.1007/s00401-009-0521-4
Woodhouse A; Shepherd CE; Sokolova A; Carroll V; King AE; Halliday GM; Dickson TC; Vickers J, 2009, 'Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease', ACTA Neuropathologica, vol. 117, pp. 19 - 29, http://dx.doi.org/10.1007/s00401-008-0458-z
Sokolova A; Hill MD; Rahimi F; Warden LA; Halliday GM; Shepherd CE, 2009, 'Monocytle chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease', Brain Pathology, vol. 19, pp. 392 - 398, http://dx.doi.org/10.1111/j.1750-3639.2008.00188.x
Shepherd CE; Gregory G; Warden L; Halliday G, 2009, 'O2‐03‐02: Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease', Alzheimer's & Dementia, vol. 5, pp. P107 - P107, http://dx.doi.org/10.1016/j.jalz.2009.05.335
Shepherd CE; Grace E; Mann DM; Halliday GM, 2007, 'Relationship between neuronal loss and 'inflammatory plaques' in early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, vol. 33, pp. 328 - 333, http://dx.doi.org/10.1111/j.1365-2990.2006.00816.x
Shepherd CE; Goyette JD; Utter V; Rahimi F; Yang Z; Geczy C; Halliday GM, 2006, 'Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease', Neurobiology of Aging, vol. 27, pp. 1554 - 1563, http://dx.doi.org/10.1016/j.neurobiolaging.2005.09.033
Rahimi F; Shepherd CE; Halliday GM; Geczy C; Raftery MJ, 2006, 'Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue', Analytical Chemistry, vol. 78, pp. 7216 - 7221, http://dx.doi.org/10.1021/ac060294s
David DJ; Ittner L; Gehrig P; Nergenau D; Shepherd CE; Halliday GM; Gotz J, 2006, 'Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes', Proteomics, vol. 6, pp. 6566 - 6577, http://dx.doi.org/10.1002/pmic.200600634
Götz J; David D; Ittner L; Halliday G; Shepherd C, 2006, 'S5–03–01: Animal and cellular models – tau–Abeta interaction', Alzheimer's & Dementia, vol. 2, pp. S92 - S92, http://dx.doi.org/10.1016/j.jalz.2006.05.362
Halliday GM; Song YC; Lepar GS; Brooks WS; Kwok JB; Kersaitis C; Gregory GC; Shepherd CE; Rahimi F; Schofield PR; Kril J, 2005, 'Pick bodies in a family with presenilin-1 Alzheimer's disease', Annals of Neurology, vol. 57, pp. 139 - 143, http://dx.doi.org/10.1002/ana.20366
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow HS; Cartwright M; Griffiths F; Shepherd CE; Double KL, 2005, 'alpha-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson`s disease', Brain, vol. 128, pp. 2654 - 2664, http://dx.doi.org/10.1093/brain/awh584
Broe M; Shepherd CE; Mann DM; Milward EA; Gai WP; Kettle E; Halliday GM, 2005, 'Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation', Neurotoxicity Research, vol. 7, pp. 69 - 76, http://dx.doi.org/10.1007/BF03033777
Shepherd CE; Gregory GC; Vickers J; Halliday GM, 2005, 'Novel 'inflammatory plaque' pathology in presenelin-1 Alzheimer's disease', Neuropathology and Applied Neurobiology, vol. 31, pp. 503 - 511, http://dx.doi.org/10.1111/j.1365-2990.2005.00667.x
Shepherd CE; Gregory GC; Vickers J; Brooks WS; Kwok J; Schofield PR; Kril J; Halliday GM, 2004, 'Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques', Neurobiology of Disease, vol. 15, pp. 115 - 119, http://dx.doi.org/10.1016/j.nbd.2003.10.008
Shepherd CE; Piguet O; Broe G; Creasey H; Waite LM; Brooks WS; Kril J, 2004, 'Histocompatibility antigens, aspirin use and cognitive performance in non-demented elderly subjects', Journal of Neuroimmunology, vol. 148, pp. 178 - 182, http://dx.doi.org/10.1016/j.jneuroim.2003.11.007
Broe M; Hodges JR; Schofield E; Shepherd CE; Kril J; Halliday GM, 2003, 'Staging disease severity in pathologically confirmed cases of frontotemporal dementia', Neurology, vol. 60, pp. 1005 - 1011, http://dx.doi.org/10.1212/01.WNL.0000052685.09194.39
Stanford PM; Shepherd CE; Halliday GM; Brooks WS; Schofield PR, 2003, 'Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia', Brain, vol. 126, pp. 814 - 826, http://dx.doi.org/10.1093/brain/awg090
Schofield E; Kersaitis C; Shepherd CE; Kril J; Halliday GM, 2003, 'Severity of gliosis in Pick`s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders', Brain, vol. 126, pp. 827 - 840, http://dx.doi.org/10.1093/brain/awg085
Munch G; Shepherd CE; Mccann H; Brooks WS; Kwok JB; Arendt T; Hallupp M; Schofield PR; Martins RN; Halliday GM, 2002, 'Intraneuronal advanced glycation endproducts in presenilin-l Alzheimer's disease', Neuroreport, vol. 13, pp. 601 - 604
Shepherd CE; Mccann H; Kettle E; Halliday GM, 2002, 'Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy Bodies', Neurobiology of Disease, vol. 9, pp. 249 - 257, http://dx.doi.org/10.1006/nbdi.2001.0469
Mackenzie IRA; Halliday G; Shepherd C, 2001, 'Cortical inflammation in dementia with Lewy bodies [3] (multiple letters)', Archives of Neurology, vol. 58, pp. 519 - 520, http://dx.doi.org/10.1001/archneur.58.3.519
Shepherd CE; Kettle E; Mccann H; Halliday GM, 2001, 'Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.', Neurobiology of Disease, vol. 8, pp. 136 - 146, http://dx.doi.org/10.1006/nbdi.2000.0361
Broe M; Shepherd CE; Halliday GM; Milward EA, 2001, 'Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies.', ACTA Neuropathologica, vol. 101, pp. 616 - 624
Halliday GM; Shepherd CE, 2001, 'Cortical inflammation in dementia with Lewy bodies.', Archives of Neurology, vol. 58, pp. 519 - 520, http://dx.doi.org/10.1001/archneur.58.3.519
Shepherd CE; Bowes S; Parkinson D; Cambray-Deakin M; Pearson RCA, 2000, 'Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock', NEUROSCIENCE, vol. 99, pp. 317 - 325, http://dx.doi.org/10.1016/S0306-4522(00)00197-4
Halliday GM; Shepherd CE; Mccann H; Reid WG; Grayson DA; Broe T; Kril J, 2000, 'Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease', Archives of Neurology, vol. 57, pp. 831 - 836, http://dx.doi.org/10.1001/archneur.57.6.831
Shepherd CE; Kettle E; Mccann H; Harding AJ; Halliday GM, 2000, 'Cortical inflammation in Alzheimer's disease but not dementia with Lewy bodies', Archives of Neurology, vol. 57, pp. 817 - 822, http://dx.doi.org/10.1001/archneur.57.6.817
Halliday GM; Robinson S; Shepherd CE; Kril J, 2000, 'Alzheimer's disease and imflammation: a review of cellular and therapeutic mechanisms', Clinical and Experimental Pharmacology and Physiology, vol. 27, pp. 1 - 8, http://dx.doi.org/10.1046/j.1440-1681.2000.03200.x
Conference Papers
Rowe C; Amadoru S; Dore V; McLean C; Hinton F; Shepherd C; Halliday G; Leyton C; Hodges J; Masters C; Villemagne V, 2018, 'Correlation of Amyloid PET in Centiloid units with neuropathological findings in Alzheimer's disease', in JOURNAL OF NUCLEAR MEDICINE, SOC NUCLEAR MEDICINE INC, PA, Philadelphia, presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), PA, Philadelphia, 23 June 2018 - 26 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000467489900482&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dobson-Stone C; Luty A; Thompson E; Blumbergs P; Brooks W; Shepherd C; Yerbury J; Halliday G; Schofield P; Kwok J, 2016, 'Identification Of A novel FTD-MND gene on chromosome 16', in JOURNAL OF NEUROCHEMISTRY, WILEY-BLACKWELL, GERMANY, Munich, pp. 230 - 230, presented at 10th International Conference on Frontotemporal Dementias, GERMANY, Munich, 31 August 2016 - 02 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000382568400030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Wong J; Shepherd CE; Kim WS; Garner B; Weickert CS, 2010, 'IS THERE EVIDENCE FOR OXIDATIVE STRESS IN THE PREFRONTAL CORTEX OF PATIENTS WITH SCHIZOPHRENIA?', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, INFORMA HEALTHCARE, pp. A19 - A19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282954700048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shepherd CE; Hill MM; Small D; Halliday , 2010, 'Decreases in receptor-associated protein in Alzheimer's disease human brain tossie correlate with increased plaque load', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 183 - 183, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
Yeung ; Halliday ; Shepherd CE, 2010, 'Tau deposition correlates with inflammation in Alzheimer's disease', in Small D (ed.), Australian Neurosciences Society Annual Scientific Meeting 2010, ANS, Sydney, pp. 183 - 183, presented at Australian Neurosciences Society Annual Scientific Meeting 2010, Sydney, 31 January 2010 - 03 February 2010
Shepherd CE; Warden LA; Guillemin GJ, 2009, 'Inflammatory effects of Abeta alloforms and conformations on human astrocytes', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. P482 - P482, presented at *, Vienna, Austria, 11 July 2009 - 16 July 2009
Halliday GM; Warden LA; Gregory GC; Kwok JB; Schofield PR; Guillemin GJ; Shepherd CE, 2009, 'Mass buildup of soluble oligomeric Abeta40 occurs in sporadic Alzheimer's disease', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. P302 - P302, presented at *, Vienna, Austria, 11 July 2009 - 16 July 2009
Warden LA; Halliday GM; Guillemin GJ; Shepherd CE, 2009, 'Comparable neurotoxicity of oligomeric AB40 and AB 42 in a human in vitro model', in Neurodegenerative Diseases, Karger, Basel, pp. 381 - 381, presented at 9th International Conference AD/PD, Prague, 11 March 2009 - 15 March 2009
Woodhouse A; Carroll V; Sokolova A; Shepherd CE; Halliday GM; Dickson TC; Vickers J, 2008, 'Preseninil-1 familial Alzheimer's disease cases exhibit altered pathology in comparison to sporadic AD', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 113 - 113, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008
Warden LA; Guillemin GJ; Halliday GM; Shepherd CE, 2008, 'neuronal viability and tau pathology is not affected in huamn primary neurons co-cultured with astrocytes following stimulation with soluble abeta oligomers', in Proceedings of Aust Neuroscience Society, Australian Neuroscience Society 28th Annual Meeting, Hobart, pp. 113 - 113, presented at Australian Neuroscience Society 28th Annual Meeting, Hobart, 27 January 2008 - 30 January 2008
Gotz J; David DJ; Ittner L; Halliday GM; Shepherd CE, 2006, 'Animal and cellular models - Tau-Abeta interaction', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. S92 - S92, presented at Alzheimer`s Association 10th International Conference of Alzheimer`s Disease and Related Disorders, Madrid, Spain, 15 July 2006 - 20 July 2006
Shepherd CE; Gregory GC; Warden LA; Halliday GM, 2006, 'Oligomeric AB40 species accumulate in the toxic plaques in Alzheimer's disease', in Khachaturian Z (ed.), Alzheimer's and Dementia, Elsevier, Orlando, Florida, pp. 107 - 107, presented at Alzheimer's Association 10th International Conference of Alzheimer's Disease and Related Disorders, Madrid, Spain, 15 July 2006 - 20 July 2006
Shepherd CE; Grace E; Mann DM; Halliday GM, 2006, 'Novel inflammatory plaques are not associated with greater neuronal cell loss', in Proceedings of Aust Neuroscience Society, 26th Annual meeting of the Australian Neuroscience Society, Sydney, pp. 151 - 151, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006
Rahimi F; Raftery MJ; Halliday GM; Geczy C; Shepherd CE, 2006, 'Proteomic analysis of formalin-fixed brain tissue is potentially applicable to laser-microdissected specimens', in Proceedings of Aust Neuroscience Society, 26th Annual meeting of the Australian Neuroscience Society, Sydney, pp. 41 - 41, presented at 26th Annual meeting of the Australian Neuroscience Society, Sydney, 31 January 2006 - 03 February 2006
Rahimi F; Goyette J; Raftery MJ; Shepherd CE; Halliday GM; Geczy C, 2005, 'S100A9, an inflammation-associated calcium-binding protein, is a binding partner for various redox-regulating proteins in familial Alzheimer's disease', in Journal of the Neurological Sciences, Elsevier Science BV, Amsterdam, Netherlands, pp. S298 - S298, presented at XVIIIth World Congress of Neurology, Sydney, 05 November 2005 - 11 November 2005
Shepherd CE; Goyette J; Utter V; Rahimi F; Yang Z; Geczy C; Halliday GM, 2005, 'Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease', in Proceedings of Aust Neuroscience Society, 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, pp. 131 - 131, presented at 25th Annual Meeting of the Australian Neuroscience Society, Perth, WA, 30 January 2005 - 02 February 2005
Goyette J; Shepherd CE; Halliday GM; Geczy C, 2004, 'S100 proteins in Alzheimer's disease', in Australian Health and Medical Research Congress, Australian Health and Medical Research Congress 2004, Sydney, Convention & Exhibition Centre, pp. 206 - 206, presented at Australian Health and Medical Research Congress 2004, Sydney, Convention & Exhibition Centre, 21 November 2004 - 26 November 2004
Gregory GC; Kwok JB; Shepherd CE; Schofield PR; Halliday GM, 2004, 'Tau deposition in familial Alzheimer`s disease', in Australian Health and Medical Research Congress, Australian Health and Medical Research Congress 2004, Sydney, Convention & Exhibition Centre, pp. 227 - 227, presented at Australian Health and Medical Research Congress 2004, Sydney, Convention & Exhibition Centre, 21 November 2004 - 26 November 2004
Shepherd CE; Schofield E; Gregory GC; Halliday GM, 2004, 'Non-hyperphosphorylated tau accumulates in the pathological hallmarks in presenilin-1 Alzheimer's disease and frontotemporal dementia', in Neurobiology of Aging, Elsevier Science Inc, New York, NY, USA, pp. S428 - S429, presented at 9th International Conference on Alzheimer`s Disease and Related Disorders, Philadelphia, Pennsylvania, 17 July 2004 - 22 July 2004, http://dx.doi.org/10.1016/S0197-4580(04)81410-6
Gregory GC; Kwok JB; Shepherd CE; Brooks WS; Xuereb J; Schofield PR; Halliday GM, 2004, 'Beta-amyloid toxicity in Alzheimer's disease', in Proceedings of Aust Neuroscience Society, 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, pp. 42 - 42, presented at 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, 27 January 2004 - 30 January 2004
Shepherd CE; Gregory GC; Vickers J; Halliday GM, 2004, 'Novel inflammatory pathology in presenilin 1 Alzheimer's disease', in Proceedings of Aust Neuroscience Society, 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, pp. 153 - 153, presented at 24th Annual Meeting of the Australian Neuroscience Society, Melbourne Convention Centre, 27 January 2004 - 30 January 2004
Shepherd CE; Schofield E; Gregory GC; Halliday GM; Kersaitis C; Kril J, 2003, 'Inflammation and neurodegeneration', in Journal of Clinical Neuroscience, Churchill Livingstone, Edinburgh, Midlothian, Scotland, pp. 780 - 781, presented at Australian Association of Neurologists Annual Scientific Meeting 2003, Darling Harbour, Sydney, 13 May 2003 - 16 May 2003
Broe M; Jensen PH; Shepherd CE; Halliday GM, 2003, 'Selective dopamine cell loss in Parkinson`s disease correlates with increased cellular alpha-synuclein', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 901 - 0901, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003
Shepherd CE; Stanford PM; Brooks WS; Kwok JB; Schofield PR; Brodaty H; Martins RN; Halliday GM, 2003, 'Absence of tau pathology in a familial frontotemporal dementia case with a mutation in the tau gene', in Proceedings of Aust Neuroscience Society, 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, pp. 375 - 375, presented at 23rd Annual Meeting of the Australian Neuroscience Society, Adelaide, Sth Aust, 28 January 2003 - 31 January 2003
Gregory GC; Shepherd CE; Kwok JB; Schofield PR; Halliday GM, 2002, 'A beta pathology in presenilin-1 Alzheimer's disease', in Australian Health and Medical Research Congress, Australian Health and Medical Research Congress 2002, Melbourne Convention Centre, pp. 2648 - 2648, presented at Australian Health and Medical Research Congress 2002, Melbourne Convention Centre, 24 November 2002 - 29 November 2002
Shepherd C; Gregory G; McCann H; Halliday G; Kwok J; Schofield P; Kril J, 2002, 'Plaque pathology in presenilin-1 Alzheimer's disease', in NEUROBIOLOGY OF AGING, ELSEVIER SCIENCE INC, pp. S220 - S220, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177465300812&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Broe M; Shepherd CE; Gai WP; Milward EA; Kettle E; Halliday GM, 2002, 'Alpha synuclein and Alzheimer's disease', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 130 - 130, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002
Schofield E; Kersaitis C; Shepherd CE; Kril J; Halliday GM, 2002, 'Tau positive microglia in trontotemporal dementia', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 148 - 148, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002
Kersaitis C; Schofield E; Shepherd CE; Kril J; Halliday GM, 2002, 'The staging of neuropathology in frontotemporal dementia', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 146 - 146, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002
Shepherd CE; Mccann H; Gregory GC; Kwok JB; Kril J; Halliday GM, 2002, 'Plaque pathology in presenelin-1 Alzheimer's disease', in Proceedings of Aust Neuroscience Society, 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, pp. 31 - 31, presented at 22nd Annual meeting of the Australian Neuroscience Society, Darling Harbour, Sydney, 04 February 2002 - 06 February 2002
Shepherd CE; Kril J; Halliday GM, 2001, 'Specificity of inflammatory pathology for Alzheimer's disease.', in Proceedings of Aust Neuroscience Society, 21st Annual Meeting of the Australian Neuroscience Society, Brisbane, Qld, pp. 134 - 134, presented at 21st Annual Meeting of the Australian Neuroscience Society, Brisbane, Qld, 28 January 2001 - 31 January 2001
Shepherd C; Kril J; Halliday G, 2000, 'Specificity of inflammatory pathology for Alzheimer's disease.', in BRAIN PATHOLOGY, INT SOC NEUROPATHOLOGY, pp. 709 - 709, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000088213000459&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
CHESSWILLIAMS R; SHEPHERD CE; COULDWELL CJ; REYNOLDS GP, 1995, 'THE ACTIONS OF CLOZAPINE, CHLORPROMAZINE AND THIORIDAZINE AT THE A(1)-ADRENOCEPTORS OF THE RAT VAS-DEFERENS AND SPLEEN', in BRITISH JOURNAL OF PHARMACOLOGY, STOCKTON PRESS, pp. P205 - P205, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RZ54500205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Posters
Rahimi F; Goyette JD; Shepherd CE; Halliday GM; Geczy C; Raftery M, 2005, 'S100A9, an inflammation-associated calcium-binding protein, is a binding partner for various redox-regulating proteins in familial Alzheimer's disease', in Journal of the Neurological Sciences, Elsevier Science BV, Sydney, AUSTRALIA, Vol. 238, pp. S298 - S298, presented at 18th World Congress of Neurology, Sydney, AUSTRALIA, 05 November 2005 - 11 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235088002393&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Conference Presentations
Halliday GM; Shepherd CE; Mccann H, 2009, 'Genetic forms of Alzheimer's disease: What can they tell us?', in Genetic forms of Alzheimer's disease: What can they tell us?, 48th ASMR National Scientific Conference, Hobart, presented at 48th ASMR National Scientific Conference, Hobart, 15 November 2009 - 17 November 2009
Conference Abstracts
Poljak A; Braidy N; Maclean C; Shepherd C; Raftery MJ; Sachdev PS, 2017, 'Proteomics of the Alzheimer's disease brain: Neuropathology and neuroresilience [Poster Abstract P2-155]', in Alzheimer's and Dementia, Elsevier, London, UK, Vol. 13, pp. P667 - P667, presented at Alzheimer's Association International Conference (AAIC) 2017, London, UK, 16 July 2017 - 20 July 2017, http://dx.doi.org/10.1016/j.jalz.2017.06.806
Preprints
Amadoru S; Doré V; McLean CA; Hinton F; Shepherd CE; Halliday GM; Leyton CE; Yates PA; Hodges JR; Masters CL; Villemagne VL; Rowe CC, 2019, Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s Disease, http://dx.doi.org/10.21203/rs.2.17082/v1